The UK is witnessing a noticeable surge in interest surrounding copyright substances. Beyond the familiar use of psilocybin and LSD, researchers and adventurers are increasingly exploring less-charted territories, particularly this powerful hallucinogen and the relatively new cannabinoid, cannabigerol. This burgeoning scene encompasses scientific s